fludrocortisone has been researched along with Neurally Mediated Faint in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (23.08) | 18.2507 |
| 2000's | 10 (38.46) | 29.6817 |
| 2010's | 8 (30.77) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Deveau, AP; Doucette, S; Maxey, C; Parkash, R; Ritchie, D; Sheldon, R | 1 |
| Akbarzadeh, MA; Alaeddini, F; Aminorroaya, A; Apakuppakul, S; Ariannejad, H; Bozorgi, A; Emkanjoo, Z; Jalali, A; Joharimoghadam, A; Kiarsi, M; Mohammadi, R; Mohsenizade, A; Mollazadeh, R; Ngarmukos, T; Oraii, A; Oraii, S; Rahimi, B; Sadeghian, S; Shahabi, J; Tajdini, M; Tavolinejad, H | 1 |
| Hutt Centeno, E; Mayuga, KA | 1 |
| Exner, DV; Maxey, C; Ng, J; Raj, SR; Raj, V; Ritchie, D; Sheldon, RS | 1 |
| Klingenheben, T; Krahn, AD; Kus, T; Lelonek, M; McRae, M; Medina, E; Morillo, CA; Parkash, R; Raj, SR; Ritchie, D; Rose, MS; Seifer, CM; Sheldon, R; Talajic, M | 1 |
| Sheldon, R | 1 |
| Hu, X; Zhou, S; Zhu, Z | 1 |
| Kuriachan, V; Platonov, M; Sheldon, RS | 1 |
| Corcoran, SJ; Esler, M; Vaddadi, G | 1 |
| Earle, NM; González, BR; Jiménez-Cohl, P; Thieck, EJ | 1 |
| Armaganijan, LV; Guzman, JC; Morillo, CA | 1 |
| Massin, M | 1 |
| Grubb, BP | 1 |
| Bastos, S; Darrieux, F; Hachul, DT; Ludovice, AC; Scanavacca, M; Sosa, E | 1 |
| Raj, SR; Ritchie, D; Rose, S; Sheldon, RS | 1 |
| Baker, C; Freeston, M; Gracie, J; Newton, JL; Norton, M | 1 |
| da Nóbrega, AC; de Castro, RR | 1 |
| Hackel, JG; Nguyen, T; Torrisi, DJ; Verma, S | 1 |
| Buzzard, CJ; Harris, JP | 1 |
| Auld, D; Benson, DW; Campbell, R; Deal, BJ; Hulse, E; Scagliotti, D; Strasburger, JF; Strieper, M | 1 |
| Wolff, GS | 1 |
| Boehm, K; Grubb, BP; Kip, K; Kosinski, DJ | 1 |
| Atiga, WL; Calkins, H; Rowe, P | 1 |
| Calkins, H | 1 |
| McLeod, KA | 1 |
| Bloomfield, DM | 1 |
10 review(s) available for fludrocortisone and Neurally Mediated Faint
| Article | Year |
|---|---|
Evidence-based treatment for vasovagal syncope.
Topics: Evidence-Based Medicine; Fludrocortisone; Humans; Midodrine; Pacemaker, Artificial; Selective Serotonin Reuptake Inhibitors; Syncope, Vasovagal; Treatment Outcome; Vasoconstrictor Agents | 2008 |
Management strategies for recurrent vasovagal syncope.
Topics: Animals; Disease Management; Fludrocortisone; Humans; Patient Education as Topic; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Syncope, Vasovagal | 2010 |
Treatment of neurally mediated reflex syncope.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Counseling; Fludrocortisone; Fluid Therapy; Humans; Hypotension, Orthostatic; Patient Education as Topic; Plasma Substitutes; Posture; Recurrence; Selective Serotonin Reuptake Inhibitors; Sodium Chloride, Dietary; Syncope, Vasovagal | 2013 |
Neurocardiogenic syncope in children : current concepts in diagnosis and management.
Topics: Adolescent; Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Child; Fludrocortisone; Humans; Selective Serotonin Reuptake Inhibitors; Syncope, Vasovagal | 2003 |
Clinical practice. Neurocardiogenic syncope.
Topics: Adrenergic beta-Antagonists; Adult; Echocardiography; Electrocardiography; Female; Fludrocortisone; Humans; Pacemaker, Artificial; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Syncope, Vasovagal; Tilt-Table Test; Vasoconstrictor Agents | 2005 |
Syncope in athletes: a guide to getting them back on their feet.
Topics: Adolescent; Anti-Arrhythmia Agents; Diagnosis, Differential; Disopyramide; Electrocardiography; Exercise; Exercise Test; Female; Fludrocortisone; Humans; Sports; Syncope; Syncope, Vasovagal; Tilt-Table Test; Vasoconstrictor Agents | 2007 |
Unexplained syncope: clinical management.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Behavior Therapy; Cardiomyopathies; Child; Coronary Vessel Anomalies; Disopyramide; Fludrocortisone; Fluid Therapy; Heart Defects, Congenital; Heart Ventricles; Humans; Hypertension, Pulmonary; Long QT Syndrome; Medical History Taking; Metabolic Diseases; Mineralocorticoids; Myocarditis; Nervous System Diseases; Physical Examination; Physical Exertion; Sodium, Dietary; Syncope; Syncope, Vasovagal; Wolff-Parkinson-White Syndrome | 1997 |
Pharmacologic approaches to therapy for vasovagal syncope.
Topics: Atenolol; Fludrocortisone; Humans; Midodrine; Paroxetine; Randomized Controlled Trials as Topic; Syncope, Vasovagal; Treatment Outcome | 1999 |
Dysautonomia and neurocardiogenic syncope.
Topics: Adrenergic beta-Antagonists; Autonomic Nervous System Diseases; Cardiac Pacing, Artificial; Child; Child, Preschool; Diagnosis, Differential; Electrocardiography; Fludrocortisone; Humans; Mineralocorticoids; Recurrence; Syncope, Vasovagal; Tilt-Table Test | 2001 |
Strategy for the management of vasovagal syncope.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiac Pacing, Artificial; Cholinergic Antagonists; Disopyramide; Fludrocortisone; Head-Down Tilt; Humans; Selective Serotonin Reuptake Inhibitors; Syncope, Vasovagal; Tilt-Table Test; Treatment Outcome; Vasodilator Agents | 2002 |
4 trial(s) available for fludrocortisone and Neurally Mediated Faint
| Article | Year |
|---|---|
Sex Differences in Vasovagal Syncope: A Post Hoc Analysis of the Prevention of Syncope Trials (POST) I and II.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Canada; Electrocardiography; Female; Fludrocortisone; Heart Rate; Humans; Incidence; Male; Metoprolol; Middle Aged; Recurrence; Risk Factors; Sex Factors; Syncope, Vasovagal; Tilt-Table Test; Young Adult | 2020 |
Comparison of Outcomes with Midodrine and Fludrocortisone for Objective Recurrence in Treating Syncope (COMFORTS trial): Rationale and design for a multi-center randomized controlled trial.
Topics: Adrenergic alpha-1 Receptor Agonists; Anti-Inflammatory Agents; Drug Therapy, Combination; Fludrocortisone; Humans; Midodrine; Quality of Life; Recurrence; Surveys and Questionnaires; Syncope, Vasovagal; Treatment Outcome | 2021 |
Quality of life improves in vasovagal syncope patients after clinical trial enrollment regardless of fainting in follow-up.
Topics: Adult; Cost of Illness; Female; Fludrocortisone; Follow-Up Studies; Humans; Male; Metoprolol; Patient Reported Outcome Measures; Quality of Life; Sympatholytics; Syncope, Vasovagal; Time Factors; Treatment Outcome | 2019 |
Fludrocortisone for the Prevention of Vasovagal Syncope: A Randomized, Placebo-Controlled Trial.
Topics: Adult; Double-Blind Method; Female; Fludrocortisone; Humans; Male; Middle Aged; Recurrence; Syncope, Vasovagal; Young Adult | 2016 |
12 other study(ies) available for fludrocortisone and Neurally Mediated Faint
| Article | Year |
|---|---|
What can I do when first-line measures are not enough for vasovagal syncope?
Topics: Adrenergic beta-Antagonists; Adult; Combined Modality Therapy; Female; Fludrocortisone; Head-Down Tilt; Humans; Male; Middle Aged; Midodrine; Selective Serotonin Reuptake Inhibitors; Stockings, Compression; Syncope, Vasovagal; Tilt-Table Test; Treatment Outcome | 2018 |
Reply: Is There a Prevention Effect of Fludrocortisone on Vasovagal Syncope?
Topics: Fludrocortisone; Humans; Syncope, Vasovagal; Tilt-Table Test | 2016 |
Is There a Prevention Effect of Fludrocortisone on Vasovagal Syncope?
Topics: Fludrocortisone; Humans; Syncope, Vasovagal; Tilt-Table Test | 2016 |
[Postural orthostatic tachycardia syndrome (POTS): report of 15 cases].
Topics: Adolescent; Adult; Cardiovascular Agents; Case-Control Studies; Child; Female; Fludrocortisone; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Postural Orthostatic Tachycardia Syndrome; Retrospective Studies; Syncope, Vasovagal; Tilt-Table Test; Treatment Outcome; Young Adult | 2012 |
[Clinical outcome of patients with neurocardiogenic syncope (NCS) after therapy interruption].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Child; Female; Fludrocortisone; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Syncope, Vasovagal; Tilt-Table Test; Time Factors; Treatment Outcome | 2006 |
The Second Prevention of Syncope Trial (POST II)--a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: rationale and study design.
Topics: Fludrocortisone; Humans; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Research Design; Syncope, Vasovagal | 2006 |
The role of psychological factors in response to treatment in neurocardiogenic (vasovagal) syncope.
Topics: Adaptation, Psychological; Adult; Aged; Anxiety; Cross-Sectional Studies; Depression; Fear; Female; Fludrocortisone; Humans; Interviews as Topic; Male; Middle Aged; Midodrine; Stress, Psychological; Surveys and Questionnaires; Syncope, Vasovagal; Tilt-Table Test; Vasoconstrictor Agents | 2006 |
Tilt table test in the differential diagnosis of refractory "epilepsy".
Topics: Adult; Anti-Inflammatory Agents; Diagnosis, Differential; Epilepsy; Female; Fludrocortisone; Humans; Syncope, Vasovagal; Tilt-Table Test | 2006 |
Index of suspicion. Case 1. Diagnosis: neurally mediated syncope.
Topics: Adolescent; Anti-Inflammatory Agents; Diagnosis, Differential; Female; Fludrocortisone; Humans; Sodium Compounds; Syncope, Vasovagal; Tilt-Table Test | 1996 |
The medical therapy of cardioinhibitory syncope in pediatric patients.
Topics: Adrenergic Agonists; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Child; Cohort Studies; Disopyramide; Drug Combinations; Ephedrine; Fludrocortisone; Fluid Therapy; Follow-Up Studies; Heart Arrest; Humans; Incidence; Metoprolol; Pacemaker, Artificial; Recurrence; Safety; Sodium Chloride, Dietary; Syncope, Vasovagal; Tilt-Table Test; Time Factors; Treatment Outcome; Treatment Refusal | 1997 |
The postural orthostatic tachycardia syndrome: a neurocardiogenic variant identified during head-up tilt table testing.
Topics: Adult; Atenolol; Autonomic Nervous System Diseases; Erythropoietin; Female; Fludrocortisone; Humans; Male; Posture; Recombinant Proteins; Selective Serotonin Reuptake Inhibitors; Syncope, Vasovagal; Tachycardia; Tilt-Table Test | 1997 |
Management of vasovagal syncope.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Cardiac Pacing, Artificial; Disopyramide; Female; Fludrocortisone; Humans; Parasympatholytics; Selective Serotonin Reuptake Inhibitors; Syncope, Vasovagal | 1999 |